Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

229 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anti-Hinge Antibodies Recognize IgG Subclass- and Protease-Restricted Neoepitopes.
Falkenburg WJ, van Schaardenburg D, Ooijevaar-de Heer P, Tsang-A-Sjoe MW, Bultink IE, Voskuyl AE, Bentlage AE, Vidarsson G, Wolbink G, Rispens T. Falkenburg WJ, et al. Among authors: wolbink g. J Immunol. 2017 Jan 1;198(1):82-93. doi: 10.4049/jimmunol.1601096. Epub 2016 Nov 18. J Immunol. 2017. PMID: 27864476
Imaging and serum analysis of immune complex formation of radiolabelled infliximab and anti-infliximab in responders and non-responders to therapy for rheumatoid arthritis.
van der Laken CJ, Voskuyl AE, Roos JC, Stigter van Walsum M, de Groot ER, Wolbink G, Dijkmans BA, Aarden LA. van der Laken CJ, et al. Among authors: wolbink g. Ann Rheum Dis. 2007 Feb;66(2):253-6. doi: 10.1136/ard.2006.057406. Epub 2006 Jun 22. Ann Rheum Dis. 2007. PMID: 16793840 Free PMC article.
The role of the shared epitope in arthralgia with anti-cyclic citrullinated peptide antibodies (anti-CCP), and its effect on anti-CCP levels.
Bos WH, Ursum J, de Vries N, Bartelds GM, Wolbink GJ, Nurmohamed MT, van der Horst-Bruinsma IE, van de Stadt RJ, Crusius JB, Tak PP, Dijkmans BA, van Schaardenburg D. Bos WH, et al. Among authors: wolbink gj. Ann Rheum Dis. 2008 Sep;67(9):1347-50. doi: 10.1136/ard.2008.089953. Epub 2008 Apr 3. Ann Rheum Dis. 2008. PMID: 18388157
Preferential decrease in IgG4 anti-citrullinated protein antibodies during treatment with tumour necrosis factor blocking agents in patients with rheumatoid arthritis.
Bos WH, Bartelds GM, Vis M, van der Horst AR, Wolbink GJ, van de Stadt RJ, van Schaardenburg D, Dijkmans BA, Lems WF, Nurmohamed MT, Aarden L, Hamann D. Bos WH, et al. Among authors: wolbink gj. Ann Rheum Dis. 2009 Apr;68(4):558-63. doi: 10.1136/ard.2008.088401. Epub 2008 Apr 29. Ann Rheum Dis. 2009. PMID: 18445623
229 results